Communicating with the FDA: the "third rail" of a new model for drug development
- PMID: 18199890
- DOI: 10.1177/0091270007313560
Communicating with the FDA: the "third rail" of a new model for drug development
Comment on
-
Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006.J Clin Pharmacol. 2008 Feb;48(2):146-56. doi: 10.1177/0091270007311111. J Clin Pharmacol. 2008. PMID: 18199891
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
